Concept of treatment and adjustment of DNA molecule.
Natali_Mis/Shutterstock

Emerging

Article Abstracts
Feb 28, 2025

Emerging

In Vivo Gene Editing

Article Abstracts
Apr 23, 2025

Several companies are experimenting on human subjects to develop gene editing that is performed inside the body. Such therapies differ from a recently approved treatment for sickle-cell anemia that removes bone marrow from the body before editing the genetic material and reintroducing it into the patient.

Intellia Therapeutics and Regeneron Pharmaceuticals are in clinical trials to use gene editing to knock out a gene that causes fibrous protein clumps, which can accumulate in organs and nerves, increasing the risk of heart failure and other serious complications. Verve Therapeutics is enrolling patients to test a gene-editing protocol designed to reverse the effects of a genetic disease that leads to severely elevated cholesterol and increased risk of early-onset cardiovascular disease.

One caveat: These therapies carry the risk of editing unrelated genes.

 

 
REFERENCES
Advanced Search on this topic

Other Articles in this category

Apr 21, 2025 | Emerging
by Sandra Yeyati   April 22 marks the 55th anniversary of Earth Day, the worldwide annual event that fosters environmental awareness and champions…
Jan 31, 2025 | Emerging
A study led by researchers from the University of New Mexico Health Sciences Center and published in Toxicological Sciences found nano- and…
Jul 18, 2023 | Emerging
Aspartame is one of the world’s most popular artificial sweeteners, found in many favorite sugar-free alternatives like Diet Coke, Trident sugar-free…
Jul 01, 2023 | Emerging
by Sarah Stegner   Deriving their deep red color from phytonutrients called betalains, beets are rich in nitrates, which help to lower blood pressure…

Customer Service

KnoWEwell News Updates